122 related articles for article (PubMed ID: 38387396)
1. 3-Amide-β-carbolines block the cell cycle by targeting CDK2 and DNA in tumor cells potentially as anti-mitotic agents.
Zhi D; An Z; Li L; Zheng C; Yuan X; Lan Y; Zhang J; Xu Y; Ma H; Li N; Wang J
Bioorg Chem; 2024 Apr; 145():107216. PubMed ID: 38387396
[TBL] [Abstract][Full Text] [Related]
2.
Ma H; Yu H; Li Z; Cao Z; Du Y; Dai J; Zhi D; Xu Y; Li N; Wang J
Front Immunol; 2022; 13():922183. PubMed ID: 36325324
[No Abstract] [Full Text] [Related]
3. Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity.
Tokala R; Sana S; Lakshmi UJ; Sankarana P; Sigalapalli DK; Gadewal N; Kode J; Shankaraiah N
Bioorg Chem; 2020 Dec; 105():104357. PubMed ID: 33091673
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and In Vitro Antitumor Activity of Novel Bivalent
Gu H; Li N; Dai J; Xi Y; Wang S; Wang J
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30326662
[TBL] [Abstract][Full Text] [Related]
5. Design of beta-carboline derivatives as DNA-targeting antitumor agents.
Guan H; Chen H; Peng W; Ma Y; Cao R; Liu X; Xu A
Eur J Med Chem; 2006 Oct; 41(10):1167-79. PubMed ID: 16790297
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
[TBL] [Abstract][Full Text] [Related]
7. Development of β-carboline-benzothiazole hybrids via carboxamide formation as cytotoxic agents: DNA intercalative topoisomerase IIα inhibition and apoptosis induction.
Tokala R; Mahajan S; Kiranmai G; Sigalapalli DK; Sana S; John SE; Nagesh N; Shankaraiah N
Bioorg Chem; 2021 Jan; 106():104481. PubMed ID: 33261848
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of new β-carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors.
Kovvuri J; Nagaraju B; Nayak VL; Akunuri R; Rao MPN; Ajitha A; Nagesh N; Kamal A
Eur J Med Chem; 2018 Jan; 143():1563-1577. PubMed ID: 29129513
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors.
Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A
Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
[TBL] [Abstract][Full Text] [Related]
11. Discovery of β-carboline-(phenylsulfonyl)furoxan hybrids as potential anti-breast cancer agents.
Hu X; Gao X; Gao G; Wang Y; Cao H; Li D; Hua H
Bioorg Med Chem Lett; 2021 May; 40():127952. PubMed ID: 33744443
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel hybrids β-carboline-4-thiazolidinones as potential antitumor and antiviral agents.
Barbosa VA; Baréa P; Mazia RS; Ueda-Nakamura T; Costa WFD; Foglio MA; Goes Ruiz ALT; Carvalho JE; Vendramini-Costa DB; Nakamura CV; Sarragiotto MH
Eur J Med Chem; 2016 Nov; 124():1093-1104. PubMed ID: 27792980
[TBL] [Abstract][Full Text] [Related]
13. β-Carboline tethered cinnamoyl 2-aminobenzamides as class I selective HDAC inhibitors: Design, synthesis, biological activities and modelling studies.
Namballa HK; Anchi P; Lakshmi Manasa K; Soni JP; Godugu C; Shankaraiah N; Kamal A
Bioorg Chem; 2021 Dec; 117():105461. PubMed ID: 34753060
[TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of DNA-Interactive β-Carboline-Oxindole Hybrids as Cytotoxic and Apoptosis-Inducing Agents.
Tokala R; Thatikonda S; Vanteddu US; Sana S; Godugu C; Shankaraiah N
ChemMedChem; 2018 Sep; 13(18):1909-1922. PubMed ID: 30010248
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationship studies of novel 3,9-substituted α-carboline derivatives with high cytotoxic activity against colorectal cancer cells.
Lin YC; Chen YF; Tseng LS; Lee YH; Morris-Natschke SL; Kuo SC; Yang NS; Lee KH; Huang LJ
Eur J Med Chem; 2016 Mar; 110():98-114. PubMed ID: 26820553
[TBL] [Abstract][Full Text] [Related]
16. Inspired by bis-β-carboline alkaloids: Construction and antitumor evaluation of a novel bis-β-carboline scaffold as potent antitumor agents.
Liu W; Wang M; Guo Z; He Y; Jia H; He J; Miao S; Ding Y; Wang S
Bioorg Chem; 2023 Apr; 133():106401. PubMed ID: 36746025
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of some β-carboline derivatives as multi-target anticancer agents.
Abdelsalam MA; AboulWafa OM; Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N
Future Med Chem; 2018 Dec; 10(24):2791-2814. PubMed ID: 30539666
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxicity of a novel series of saframycin-ecteinascidin analogs containing tetrahydro-β-carboline moieties.
Lu X; Pan X; Yang Y; Ji M; Chen X; Xiao Z; Liu Z
Eur J Med Chem; 2017 Jul; 135():260-269. PubMed ID: 28456034
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of β-carboline derivatives with nitrogen mustard moieties against breast cancer.
Sun J; Wang J; Wang X; Hu X; Cao H; Bai J; Li D; Hua H
Bioorg Med Chem; 2021 Sep; 45():116341. PubMed ID: 34365102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
